Therapeutic options in the polycystic ovary syndrome

References

• Balen A H, Braat D D, West C, Patel A, Jacobs H S. Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients. Human Reproduction 1994; 9: 1563–1570
   PubMed Web of Science ®Google Scholar
• Balen A H, Conway G S, Homburg R, Legro R S. Polycystic ovary syndrome – a guide to clinical management. Taylor & Francis, London 2005
   Google Scholar
• Balen A H, Conway G S, Kaltsas G, Techatrasak K, Manning P J, West C, et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Human Reproduction 1995; 10: 2107–2111
   PubMed Web of Science ®Google Scholar
• Balen A H, Laven J SE, Tan S L, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Human Reproduction Update 2003; 9: 505–514
   PubMed Web of Science ®Google Scholar
• Balen A H, Tan S L, Jacobs H S. Hypersecretion of luteinising hormone – a significant cause of subfertility and miscarriage. British Journal of Obstetrics and Gynaecology 1993; 100: 1082–1089
   PubMedGoogle Scholar
• Balen A H. Polycystic ovary syndrome and cancer. Human Reproduction Update 2001; 7: 522–525
   PubMed Web of Science ®Google Scholar
• Balen A H. Ovulation induction – optimising results and minimizing risks. Human Fertility (Cambridge) 2003; 6: 42–51
   Google Scholar
• Balen A H. The current understanding of polycystic ovary syndrome. Obstetrician and Gynaecologist 2004; 6: 66–74
   Google Scholar
• Bhathena R K. The pathophysiology, prevention and management of the ovarian hyperstimulation syndrome. Journal of Obstetrics and Gynaecology 1998; 18: 405–407
   Google Scholar
• Bhathena R K. Drospirenone and the polycystic ovary syndrome. Journal of Family Planning and Reproductive Health Care 2005; 31: 81
   Google Scholar
• Biljan M, Hemmings R, Brassard N. The outcome of 150 babies following treatment with letrozole or letrozole and gonadotrophins. Annual Meeting of the American Society for Reproductive Medicine, MontrealQuebec, 2005
   Google Scholar
• BNF. British National Formulary. 51st ed. British Medical Association and Royal Pharmaceutical Society of Great Britain, London 2006; 380
   Google Scholar
• Carmina E, Lobo R A. Polycystic ovary syndrome: arguably the most common endocrinopathy is associated with significant morbidity in women. Journal of Clinical Endocrinology and Metabolism 1999; 84: 1897–1899
   PubMed Web of Science ®Google Scholar
• Cheung A P. Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome. Obstetrics and Gynaecology 2001; 98: 325–331
   PubMed Web of Science ®Google Scholar
• Christin-Maitre S, Hugues J, on behalf of the Recombinant FSH Study Group. A comparative randomised multicentric study comparing the step-up versus the step-down protocol in the polycystic ovary syndrome. Human Reproduction 2003; 18: 1626–1631
   PubMed Web of Science ®Google Scholar
• Cibula D, Hill M, Vohradnikova O, Kuzel D, Fanta M, Zivny J. The role of androgens in determining acne severity in adult women. British Journal of Dermatology 2000; 143: 399–404
   PubMed Web of Science ®Google Scholar
• Clark A M, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X, et al. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Human Reproduction 1995; 10: 2705–2712
   PubMed Web of Science ®Google Scholar
• Clark A M, Thornley B, Tomlinson L, Galletly C, Norman R J. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Human Reproduction 1998; 13: 1502–1505
   PubMed Web of Science ®Google Scholar
• Conn J J, Jacobs H S. Managing hirsutism in gynaecological practice. British Journal of Obstetrics and Gynaecology 1998; 105: 687–696
   PubMedGoogle Scholar
• Cresswell J L, Barker D J, Osmond C, Egger P, Phillips D I, Fraser R B. Fetal growth, length of gestation and polycystic ovaries in adult life. Lancet 1997; 350: 1131–1135
   PubMed Web of Science ®Google Scholar
• Daniell J F, Miller N. Polycystic ovaries treated by laparoscopic laser vaporization. Fertility and Sterility 1989; 51: 232–236
   PubMed Web of Science ®Google Scholar
• Dunaif A, Finegood D. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 1996; 81: 942–947
   PubMed Web of Science ®Google Scholar
• Dunaif A, Segal K R, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance independent of obesity in polycystic ovary syndrome. Diabetes 1989; 38: 1165–1174
   PubMed Web of Science ®Google Scholar
• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Review 1997; 18: 774–800
   PubMed Web of Science ®Google Scholar
• Elkind-Hirsch K E, Webster B W, Brown C P, Vernon M W. Concurrent ganirelix and follitropin-beta therapy is an effective and safe regimen for ovulation induction in women with the polycystic ovary syndrome. Fertility and Sterility 2003; 79: 603–607
   PubMed Web of Science ®Google Scholar
• Falsetti L, Gambera A, Plato C, Legrenzi L. Management of hirsutism. American Journal of Clinical Dermatology 2000; 1: 89–99
   PubMedGoogle Scholar
• Falsetti L, Gambera A, Tisi G. Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovary syndrome. Human Reproduction 2001; 16: 36–42
   PubMed Web of Science ®Google Scholar
• Farhi J, Soule S, Jacobs H S. Effect of laparoscopic ovarian electrocautery on ovarian response and outcome of treatment with gonadotrophins in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertility and Sterility 1995; 64: 930–935
   PubMed Web of Science ®Google Scholar
• Farquhar C, Lee O, Toomath R, Jepson R. Spironolactone verus placebo, or in combination with steroids for hirsutism and/or acne. Cochrane Database of Systemic Reviews 2001a; 4: CD000194
   Google Scholar
• Farquhar C, Vandekerckhove P, Arnot M, Lilford R. Laparoscopic ‘drilling’ by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database of Systemic Reviews 2001b; 4: CD001122
   Google Scholar
• Fatemi H M, Kolibianakis E, Tournaye H, Camus M, Van Steirteghem A C, Devroey P. Clomiphene citrate versus letrozole for ovarian stimulation: a pilot study. Reproductive Biomedicine Online 2003; 7: 543–546
   PubMedGoogle Scholar
• Fauser B, Tarlatzis B, Chang J, Azziz R, Legro R, Dewailly D, et al. The Rotterdam ESHRE/ASRM-sponsored PCOS Consenus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 2004; 19: 41–47
   PubMed Web of Science ®Google Scholar
• Ferriman D, Gallwey J D. Clinical assessment of body hair growth in women. Journal of Clinical Endocrinology and Metabolism 1961; 21: 1440–1447
   PubMed Web of Science ®Google Scholar
• Franks S, Gharani N, McCarthy M. Candidate genes in polycystic ovary syndrome. Human Reproduction Update 2001; 7: 405–410
   PubMed Web of Science ®Google Scholar
• Franks S. Molecular genetics of the polycystic ovary syndrome. Female infertility therapy, Z Shoham, C M Howles, H S Jacobs. Martin Dunitz, London 1999; 35–43
   Google Scholar
• Gadir A A, Khatim M S, Mowafi R S, Alnaser H M, Muharib N S, Shaw R W. Implications of ultrasonically diagnosed polycystic ovaries. 1. Correlations with basal hormonal profiles. Human Reproduction 1992; 7: 453–457
   PubMed Web of Science ®Google Scholar
• Gjoannaess H. Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope. Fertility and Sterility 1984; 41: 20–25
   PubMed Web of Science ®Google Scholar
• Glueck C J, Wang P, Goldenberg N, Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Human Reproduction 2002; 17: 2858–2864
   PubMed Web of Science ®Google Scholar
• Gysler M, March C M, Mishell D R, Bailey E J. A decade's experience with an individualised clomiphene treatment regimen including its effects on the postcoital test. Fertility and Sterility 1982; 37: 161–167
   PubMed Web of Science ®Google Scholar
• Haakova L, Cibula D, Rezabek K, Hill M, Fanta M, Zivny J. Pregnancy outcome in women with PCOS and in controls matched by age and weight. Human Reproduction 2003; 18: 1438–1441
   PubMed Web of Science ®Google Scholar
• Hayden C J, Rutherford A J, Balen A H. Induction of ovulation with the use of a starting dose of 50 units of recombinant human follicle stimulating hormone. Fertility and Sterility 1999; 71: 106–108
   PubMed Web of Science ®Google Scholar
• Homburg R, Armar N A, Eshel A, Adams J, Jacobs H S. Influence of serum luteinising hormone concentrations on ovulation, conception and early pregnancy loss in polycystic ovary syndrome. British Medical Journal 1988; 297: 1024–1026
   PubMed Web of Science ®Google Scholar
• Homburg R, Howles C M. Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, reflections and refinements. Human Reproduction Update 1999; 5: 493–499
   PubMed Web of Science ®Google Scholar
• Homburg R. Should patients with polycystic ovary syndrome be treated with metformin?. Human Reproduction 2002; 17: 853–856
   PubMed Web of Science ®Google Scholar
• Imani B, Eijkemans M J, te Velde E R, Habbema J D, Fauser B C. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotrophic oligomenorrhoeic infertility. Journal of Clinical Endocrinology and Metabolism 1998; 83: 2361–2365
   PubMed Web of Science ®Google Scholar
• Jakubowicz D J, Iuorno M J, Jakubowicz S, Roberts K A, Nestler J E. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2002; 87: 524–529
   PubMed Web of Science ®Google Scholar
• Kelly C J, Cameron I T, Gould G W, Lyall H. The long-term health risks of the polycystic ovary syndrome. British Journal of Obstetrics and Gynaecology 2000; 107: 1327–1338
   Google Scholar
• Kiddy D S, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed M J, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clinical Endocrinology (Oxford) 1992; 36: 105–111
   PubMed Web of Science ®Google Scholar
• Kolodziejczyk B, Duleba A J, Spaczynski R Z, Pawelczyk L. Metformin therapy decreases hyperandrogenism and hyperinsulinaemia in women with the polycystic ovary syndrome. Fertility and Sterility 2000; 73: 1149–1154
   PubMed Web of Science ®Google Scholar
• Kousta E, White D M, Cela E, McCarthy M I, Franks S. The prevalence of polycystic ovaries in women with infertility. Human Reproduction 1999; 14: 2720–2723
   PubMed Web of Science ®Google Scholar
• Kousta E, White D M, Franks S. Modern use of clomiphene citrate in induction of ovulation. Human Reproduction Update 1997; 3: 359–365
   PubMed Web of Science ®Google Scholar
• Laven J S, Imani B, Eijkemans M J, Fauser B C. New approaches to PCOS and other forms of anovulation. Obstetric and Gynaecological Survey 2002; 57: 755–767
   PubMedGoogle Scholar
• Legro R S, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 1998; 83: 2694–2698
   PubMed Web of Science ®Google Scholar
• Lord J M, Flight I H, Norman R J. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Systematic Reviews 2003a; 3: CD003053
   Google Scholar
• Lord J M, Flight I H, Norman R J. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. British Medical Journal 2003b; 327: 951–955
   PubMed Web of Science ®Google Scholar
• MacGregor A H, Johnson J E, Bunde C A. Further clinical experience with clomiphene citrate. Fertility and Sterility 1968; 19: 616–622
   PubMed Web of Science ®Google Scholar
• Malhotra B, Noveck R, Behr D, Palmisano M. Percutaneous absorption and pharmacokinetics of eflornithine hcl 13.9% cream in women with unwanted facial hair. Journal of Clinical Pharmacology 2001; 41: 972–978
   PubMed Web of Science ®Google Scholar
• Mather K J, Kwan F, Corenblum B. Hyperinsulinaemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity. Fertility and Sterility 2000; 73: 150–156
   PubMed Web of Science ®Google Scholar
• Mercurio M G. Hirsutism: diagnosis and management. Journal of Gender Specific Medicine 2001; 4: 29–34
   PubMedGoogle Scholar
• Moran L J, Noakes M, Clifton P M, Tomlison L, Norman R J. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2003; 88: 812–819
   PubMed Web of Science ®Google Scholar
• Nardo L G, Rai R, Backos M, El Gaddal S, Regan L. High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage. Fertility and Sterility 2002; 77: 348–352
   PubMed Web of Science ®Google Scholar
• NICE Clinical Guideline. Fertility: assessment and treatment for people with fertility problems. National Institute for Clinical Excellence, London 2004
   Google Scholar
• Norman R J, Davies M J, Lord J, Moran L J. The role of lifestyle modification in polycystic ovary syndrome. Trends in Endocrinology and Metabolism 2002; 13: 251–257
   PubMed Web of Science ®Google Scholar
• Nugent D, Salha O, Balen A H, Rutherford A J. Ovarian neoplasia and subfertility treatments. British Journal of Obstetrics and Gynaecology 1998; 105: 584–591
   PubMedGoogle Scholar
• O'Driscoll J B, Mamtora H, Higginson J, Pollock A, Kane J, Anderson D C. A prospective study of the prevalence of clearcut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. Clinical Endocrinology (Oxford) 1994; 41: 231–236
   PubMed Web of Science ®Google Scholar
• Palep-Singh M, Barth J H, Mook K, Balen A H. An observational study of Yasmin in the management of polycystic ovary syndrome. Journal of Family Planning and Reproductive Health Care 2004; 30: 163–165
   PubMed Web of Science ®Google Scholar
• Porcile A, Gallardo E. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives. Fertility and Sterility 1991; 55: 877–881
   PubMed Web of Science ®Google Scholar
• Poretsky L, Cataldo N A, Rosenwaks Z, Giudice L A. The insulin-related ovarian regulatory system in health and disease. Endocrinological Review 1999; 20: 535–582
   PubMed Web of Science ®Google Scholar
• Radon P A, McMahon M J, Meyer W R. Impaired glucose tolerance in pregnant women with the polycystic ovary syndrome. Obstetrics and Gynaecology 1999; 94: 194–197
   PubMed Web of Science ®Google Scholar
• Rai R, Backos M, Rushworth F, Regan L. Polycystic ovaries and recurrent miscarriage – a reappraisal. Human Reproduction 2000; 15: 612–615
   PubMed Web of Science ®Google Scholar
• Rajkhowa M, Glass M R, Rutherford A J, Michelmore K, Balen A H. Polycystic ovary syndrome: a risk factor for cardiovascular disease?. British Journal of Obstetrics and Gynaecology 2000; 107: 11–18
   Google Scholar
• RCOG. Guideline No. 33: Long-term consequences of polycystic ovary syndrome. Royal College of Obstetricians and Gynaecologists, London 2003
   Google Scholar
• Rodin D A, Bano G, Bland J M, Taylor K, Nussey S S. Polycystic ovaries and associated metabolic abnormalities in Indian subcontinental Asian women. Clinical Endocrinology (Oxford) 1998; 49: 91–99
   PubMed Web of Science ®Google Scholar
• Rossing M A, Dalling J R, Weiss N S, Moore D E, Self S G. Ovarian tumours in a cohort of infertile women. New England Journal of Medicine 1994; 331: 771–776
   PubMed Web of Science ®Google Scholar
• Sahin Y, Dilber S, Kelestimur F. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism. Fertility and Sterility 2001; 75: 496–500
   PubMed Web of Science ®Google Scholar
• Shulman L H, DeRogatis L, Speivogel R, Miller J L, Rose L. Serum androgens and depression in women with facial hirsutism. Journal of the American Academy of Dermatology 1993; 27: 178–181
   Google Scholar
• Tartagni M, Schonauer L M, De Salvia M A, Cicinelli E, De Pergola G, D'Addario V. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism. Fertility and Sterility 2000; 73: 718–723
   PubMed Web of Science ®Google Scholar
• Turhan N O, Seckin N C, Aybar F, Inegol I. Assessment of glucose tolerance and pregnancy outcome of polycystic ovary patients. International Journal of Gynecology and Obstetrics 2003; 81: 163–168
   PubMed Web of Science ®Google Scholar
• Wijeyaratne C N, Balen A H, Barth J, Belchetz P E. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?. Clinical Endocrinology (Oxford) 2002; 57: 343–350
   PubMed Web of Science ®Google Scholar
• Wild S, Pierpoint T, McKeigue P, Jacobs H. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow up: a retrospective cohort study. Clinical Endocrinology 2000; 52: 595–600
   PubMed Web of Science ®Google Scholar